Information Provided By: 
Fly News Breaks for September 5, 2017
ISRG
Sep 5, 2017 | 07:44 EDT
Morgan Stanley analyst David Lewis raised his price target on Intuitive Surgical to $1,150 from $1,070 as he contends that the flexible catheter system in development through a joint venture with Fosun could disrupt the $6B lung biopsy market. The analyst, who estimates the FC system could be worth $80-$175 per share for Intuitive, reiterates his Overweight rating on the stock.
News For ISRG From the Last 2 Days
